ENTRY       D05917                      Drug
NAME        Stamulumab (USAN)
EFFICACY    Myostatin inhibitor
  TYPE      Monoclonal antibody
COMMENT     Treatment of muscular dystrophy and age-related sarcopenia or frailty
TARGET      MSTN [HSA:2660] [KO:K05497]
  PATHWAY   hsa04060(2660)  Cytokine-cytokine receptor interaction
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Transforming growth factors (RSTK-binding)
                MSTN
                 D05917  Stamulumab (USAN)
DBLINKS     CAS: 705287-60-1
            PubChem: 47207575
///
